About: OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.
Sector: Healthcare
Industry: Biotechnology
Latest price: $3.10 (-5.20%)
OKURNASDAQOnKure Therapeutics, Inc.
OnKure Therapeutics, Inc. share price
OKUR price activity
Last Price
$3.100
Change (24hr)
-0.17 USD (-5.20%)
Volume
253.65K
Volume (4w avg)
-
Open
$3.31
Day Range
$2.98 - $3.33
Previous Close
$3.27
Last Trade
11 Sep, 8:00 pm GMT+0
Delayed
11 Sep, 8:00 pm GMT+0
OKUR price performance
Delayed
11 Sep, 8:00 pm GMT+0
OKUR Market Signals